Mymetics (MYMX) Price & Analysis

13 Followers

MYMX Stock Chart & Stats

$0.01

$0.00(0.00%)

At close: May 11 4:00 PM EDT

$0.01

$0.00(0.00%)

Day’s Range― - ―

52-Week Range$0.01 - $0.01

Previous CloseN/A

Volume101.00

Average Volume (3M)0.00

Market Cap

$46.00

Enterprise Value$71.68M

Total Cash (Recent Filing)$62.00K

Total Debt (Recent Filing)$75.11M

Price to Earnings (P/E)―

Beta0.30

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-7.37

Shares Outstanding151,879

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio108.11

Price to Book (P/B)-262.28

Price to Sales (P/S)5673591.92

P/FCF Ratio-10.08K

Enterprise Value/Market Cap1.56M

Enterprise Value/Revenue199.31

Enterprise Value/Gross Profit-94.07

Enterprise Value/Ebitda-8.21

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

MYMX FAQ

What was Mymetics’s price range in the past 12 months?

Mymetics lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.

What is Mymetics’s market cap?

Mymetics’s market cap is $46.00.

When is Mymetics’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Mymetics’s earnings last quarter?

Mymetics released its earnings results on May 14, 2018. The company reported -$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.004.

Is Mymetics overvalued?

According to Wall Street analysts Mymetics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Mymetics pay dividends?

Mymetics does not currently pay dividends.

What is Mymetics’s EPS estimate?

Mymetics’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Mymetics have?

Mymetics has 151,879 shares outstanding.

What happened to Mymetics’s price movement after its last earnings report?

Mymetics reported an EPS of -$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.

Which hedge fund is a major shareholder of Mymetics?

Currently, no hedge funds are holding shares in MYMX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Mymetics

Mymetics Corporation is a Swiss biotechnology company dedicated to the research and development of vaccines aimed at preventing infectious and debilitating diseases. Its robust pipeline features several promising vaccine candidates, including those for HIV-1/AIDS, COVID-19, intranasal influenza, respiratory syncytial virus (RSV), malaria, and chikungunya. The company actively collaborates with leading institutions such as the Texas Biomedical Research Institute, the PATH Malaria Vaccine Initiative, and the National Institute of Allergy and Infectious Diseases' Laboratory of Malaria Immunology and Vaccinology, focusing on the development and production of virosome-based vaccine formulations for a malaria transmission-blocking agent. Additionally, Mymetics works with Sanofi Pasteur Biologics, LLC to assess the immunogenicity of influenza vaccines. Founded in 1990, the company was formerly known as ICHOR Corporation, adopting its current name in July 2001, and maintains its base of operations in Epalinges, Switzerland.